Avecho (ASX:AVE)
Company Profile
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Avecho.
RELATED STOCKHEAD STORIES
Biocurious: Sometimes an effective therapy lies not just with the drug, but how it is delivered
Health Check: Brokers slash Cochlear valuations as customers hold tight on product upgrades
Closing Bell: ASX takes breather, goldies shine, Woolies and Coles charged over sneaky discounts
ASX Small Caps Lunch Wrap: Coles and Woolies weigh after ACCC cries foul on ‘bargains’
Investor Guide: Health & Biotech FY2025 featuring Tim Boreham
Market Highlights: Reddit, Bitcoin pop; and why Aussie small caps are undervalued compared to the US
Top 10 at 11: Which biotech just received ethics approval for a Phase 3 trial?
Stockhead presents… The 12 Days of ASXmas
Rise and Shine: Everything you need to know before the ASX opens
Closing Bell: ASX rises despite tech meltdown; Domino’s fires everyone, stock jumps
ASX Health Stocks: Here’s why AHI shares jump 40pc on the ASX, and more than 100pc on Nasdaq
Check Up: Brisbane based Vaxxas set to disrupt market with game-changing, needle-free vaccines
ASX Health Stocks: Tissue Repair and Radiopharm jump double digits after US FDA meetings
